Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.58 USD | +0.91% | -2.27% | +120.53% |
May. 07 | Canaccord Genuity Adjusts Price Target on Stoke Therapeutics to $20 From $21, Maintains Buy Rating | MT |
May. 06 | Earnings Flash (STOK) STOKE THERAPEUTICS Reports Q1 Revenue $4.2M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+120.53% | 598M | |
+25.78% | 44.96B | |
-0.76% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.46% | 26.08B | |
-21.14% | 19.03B | |
+5.97% | 12.75B | |
+28.26% | 12.06B | |
-3.20% | 11.75B |
- Stock Market
- Equities
- STOK Stock
- News Stoke Therapeutics, Inc.
- Wedbush Adjusts Stoke Therapeutics' Price Target to $17 From $13, Keeps Outperform Rating